- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 9.46M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 7.97M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 1.49M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.02M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.55M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $16.07M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $2.79M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $16.75M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.34M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $2.58M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $3.38M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.4M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.21M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.99M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $16.78M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $3.38M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $19.75M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $6.33M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.27 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$1.13 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.27 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.13 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.44M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $950.77K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $694.22K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $558.74K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.18M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.67M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.26M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.75M |
| Revenue | Q1 2026 · Mar 31, 2026 | $51.94K |
| Revenue | Q1 2026 · Mar 31, 2025 | $15.62K |